Overview

Clinical Guidelines for APL Treatment

Status:
Recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

Therapeutic guidelines for treatment of patients with de novo APL to be used by every institution that wants to follow them. All patients who are reported may be retrospectively analyzed

Phase:

Phase 4

Details

Lead Sponsor:

PETHEMA Foundation

Treatments:

Idarubicin
Methotrexate